Top 5 Most-Read Articles in Metabolism and Target Organ Damage for 2024
Metabolism and Target Organ Damage (M&TOD) is excited to showcase the five most-read articles of 2024, highlighting cutting-edge research in the field of metabolism. These articles demonstrate the journal’s dedication to addressing key topics in metabolic diseases, engaging both scholars and healthcare professionals. Below is a quick overview of the top papers that have captured the most attention:
1. Obesity and Diabetes in Heart Disease in Women
• Authors: Yetunde A. Fatade, Esha K. Dave, Nishant Vatsa, Tre’Cherie Crumbs, Avery Calhoun, Ashish Sharma, Chrisandra L. Shufelt, Puja K. Mehta
• Number of Reads: 1,924 (as of February 19, 2025)
• Read the full article: https://www.oaepublish.com/articles/mtod.2023.30
• Key Points: This article examines the impact of obesity and diabetes on heart disease in women, leading to conditions such as coronary microvascular dysfunction and heart failure with preserved ejection fraction. The authors emphasize the importance of team-based care for early identification and management to improve outcomes for women with these risk factors.
Graphical Abstract
2. Diabetes Mellitus and Heart Disease
• Authors: Preethi Chandrasekaran, Ralf Weiskirchen
• Number of Reads: 1,796 (as of February 19, 2025)
• Read the full article: https://www.oaepublish.com/articles/mtod.2024.15
• Key Points: This article explores the link between diabetes and cardiovascular disease, detailing how high blood sugar damages blood vessels and contributes to heart conditions. It highlights mechanisms such as endothelial dysfunction and inflammation, stressing the importance of better diabetes control to reduce cardiovascular risks and improve patient outcomes.
Graphical Abstract
3. Marginal Ulceration after Roux-en-Y Gastric Bypass: Literature Review and Management Algorithm
• Authors: Dustin Baldwin, Ahmed M. Ali, Maria S. Altieri, Eric J. DeMaria
• Number of Reads: 1,644 (as of February 19, 2025)
• Read the full article: https://www.oaepublish.com/articles/mtod.2023.33
• Key Points: This article reviews marginal ulceration following Roux-en-Y gastric bypass, addressing factors such as surgical techniques and patient conditions. It provides a management algorithm, ranging from proton pump inhibitors to surgical options, to guide clinicians in effectively treating and preventing this complication in bariatric surgery patients.
Flow Chart
4. MASLD, MAFLD, or NAFLD Criteria: Have We Re-Created the Confusion and Acrimony Surrounding Metabolic Syndrome?
• Authors: Christopher D. Byrne, Giovanni Targher
• Number of Reads: 1,389 (as of February 19, 2025)
• Read the full article: https://www.oaepublish.com/articles/mtod.2024.06
• Key Points: This article discusses the reclassification of NAFLD to MASLD/MAFLD, reflecting the role of metabolic dysfunction in liver disease. It examines the challenges associated with the new terminology, aiming for a more accurate disease description while maintaining its association with metabolic disorders and their systemic implications.
Graphical Abstract
5. Cancer Drugs and Diabetic Retinopathy: A Dangerous, Underestimated Association
• Authors: Agostino Milluzzo, Lucia Manuella, Lucia Frittitta, Laura Sciacca
• Number of Reads: 1,006 (as of February 19, 2025)
• Read the full article: https://www.oaepublish.com/articles/mtod.2023.43
• Key Points: This article highlights the risks associated with cancer drugs that may trigger diabetic retinopathy, a leading cause of blindness. It discusses how cancer treatments may worsen retinal damage in diabetic patients and calls for further research and evidence-based protocols to prevent and manage retinopathy in these patients.
Graphical Abstract
These articles represent significant strides in understanding the interconnectedness between metabolic diseases and their implications on other health conditions. As M&TOD continues to focus on these emerging issues, we remain committed to publishing high-quality research that drives advancements in metabolic health.
Editor: Alani Luo
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage
